Nivolumab and Ipilimumab Followed by Nivolumab vs Cabozantinib with Nivolumab: A Trial in Metastatic Untreated Renal Cell Cancer (A031704)[PDIGREE]
Nivolumab and Ipilimumab Followed by Nivolumab vs Cabozantinib with Nivolumab: A Trial in Metastatic Untreated Renal Cell Cancer (A031704)[PDIGREE]
Trial Category:
Genitourinary
Phase
III
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
